Insider filing · CRL
Richard F Wallman sold $1.6M of Charles River Laboratories Inte (CRL)
Executed Nov 7 2024, disclosed Nov 12 2024, 5 days later.
Value, as filed
$1.6M
7,621 sh across 3 lots
Executed
Nov 7 2024
the trade date, as filed
Disclosed
Nov 12 2024
5 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RW
Richard F Wallman
Director
profile →
Richard F Wallman (Director) filed 3 Form 4 reports in the trailing twelve months (2 purchases, 1 sale), most often in CECO Environmental Corp. (CECO). Across 2 priced purchase filings, the average 21-session return was +15.2% from execution and +5.9% from disclosure (delay-adjusted; derived). The largest single filing was $2.3M of ROP (6,434 sh × $361.00, as filed), executed Jul 24.
The name
CRL
Charles River Laboratories Inte
CRL · Healthcare · 19 filings in 24 months
ticker →
Healthcare · Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→